Sun Sep 15 11:15:09 UTC 2024: ## Teva Pharmaceutical Industries Sees Mixed Investor Activity in Q2

**New York, NY – September 15, 2024** – Teva Pharmaceutical Industries (NYSE:TEVA) experienced a mixed bag of investor activity in the second quarter of 2024. While some investors trimmed their holdings, others significantly increased their stakes, indicating continued interest in the pharmaceutical giant.

Daiwa Securities Group Inc. reduced its Teva stake by 29.7%, selling 34,328 shares. However, other investors, such as Acadian Asset Management LLC, increased their holdings by a substantial 90.8%, acquiring 535,164 shares. Similarly, Victory Capital Management Inc. and Range Financial Group LLC also boosted their positions by 6.0% and 9.3% respectively.

Several research firms also weighed in on Teva, with most expressing optimism about the company’s future. Bank of America, Barclays, Jefferies Financial Group, Argus, and UBS Group all raised their price targets for the stock, citing strong performance and future prospects.

Despite the mixed investor activity, Teva remains a popular choice for institutional investors and hedge funds, who currently own 54.05% of the company’s stock. The company’s second-quarter earnings report, released on July 31st, showed strong performance, exceeding analysts’ expectations for both earnings per share and revenue.

However, insider activity was mixed as well. Eric A. Hughes sold 24,537 shares of the company’s stock on August 1st, while Director Roberto Mignone sold 519,000 shares on June 18th.

Teva continues to be a major player in the pharmaceutical industry, specializing in the development, manufacturing, and distribution of generic and specialty medicines. The company’s strong earnings performance and positive outlook continue to attract investors, despite the mixed activity in the second quarter.

**Disclaimer:** This is a summarized news article based on the provided text and does not constitute financial advice. Investors should consult with a qualified financial advisor before making any investment decisions.

Read More